BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2934412)

  • 1. Atriopeptin III. A potent natriuretic, diuretic, and hypotensive agent in rats with chronic renal failure.
    Cole BR; Kuhnline MA; Needleman P
    J Clin Invest; 1985 Dec; 76(6):2413-5. PubMed ID: 2934412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atriopeptins: circulating volume regulatory hormones with potential therapeutic role in chronic renal failure.
    Cole BR; Schwartz D; Manning PT; Katsube NC; Needleman P
    J Hypertens Suppl; 1986 Jun; 4(2):S13-6. PubMed ID: 2941535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of atrial natriuretic peptide on sodium homeostasis in experimental renal failure.
    Nitta K; Naruse M; Sanaka T; Tsuchiya K; Sugino N
    Jpn J Exp Med; 1989 Oct; 59(5):181-8. PubMed ID: 2533287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The action of atriopeptin III on renal function in two models of chronic renal failure in the rat.
    Johns EJ; Rutkowski B
    Br J Pharmacol; 1990 Feb; 99(2):317-22. PubMed ID: 2139350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effects of synthetic rat-atrial natriuretic peptide in nephron-reduced rats with nephrotoxic nephritis.
    Nitta K; Sanaka T; Kawaguchi H; Tsuchiya K; Sone M; Takuma T; Sugino N
    Jpn J Exp Med; 1987 Feb; 57(1):41-5. PubMed ID: 2957529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atriopeptin III alters renal medullary hemodynamics and the pressure-diuresis response in rats.
    Takezawa K; Cowley AW; Skelton M; Roman RJ
    Am J Physiol; 1987 Jun; 252(6 Pt 2):F992-1002. PubMed ID: 2954473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic haemodynamic and natriuretic effects of atriopeptin II in conscious rats.
    Hofbauer KG; Criscione L; Sonnenburg C; Muir A; Mah SC
    J Hypertens Suppl; 1986 Jun; 4(2):S41-7. PubMed ID: 2941543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic and vasodilating activities of intrarenally administered atriopeptin II, substance P and bradykinin in the dog.
    DeFelice AF; Brousseau A
    J Pharmacol Exp Ther; 1988 Jul; 246(1):183-8. PubMed ID: 2455790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the tubular effects of atrial extract and of atriopeptin III in conscious rats.
    Kramer HJ; Kipnowski J; Stekle B; Bäcker A; Predel HG; Düsing R
    Klin Wochenschr; 1986; 64 Suppl 6():31-6. PubMed ID: 2948059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of renal nerves in the hypotensive and the renal effects of atrial natriuretic factor in rats.
    Kau MM; Wu JN; Huang WC
    Chin J Physiol; 1990; 33(1):5-18. PubMed ID: 2142916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rat atriopeptin III on renal function in dogs during water diuresis and hydropenia.
    Hropot M; Klaus E; Knolle J; König W; Scholz W
    Klin Wochenschr; 1986; 64 Suppl 6():58-63. PubMed ID: 2948065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal vascular and excretory resistance to atrial natriuretic peptide in pre-cirrhotic, bile-duct ligated rats.
    Valdivieso A; Boric MP; Riquelme A; Roblero J
    Biol Res; 1993; 26(3):397-404. PubMed ID: 7606260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of brain natriuretic peptide in patients with congestive heart failure.
    Jensen KT; Eiskjaer H; Carstens J; Pedersen EB
    Clin Sci (Lond); 1999 Jan; 96(1):5-15. PubMed ID: 9857101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal natriuretic effects of atrial natriuretic peptide in dogs with alloxan-induced acute pulmonary edema.
    Levy M; Cernacek P
    Clin Invest Med; 1996 Dec; 19(6):435-43. PubMed ID: 8959353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of atrial natriuretic factor in the rats of different ages.
    Bräunlich H; Solomon S
    Physiol Bohemoslov; 1987; 36(2):119-24. PubMed ID: 2955435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats.
    Koepke JP; Tyler LD; Trapani AJ; Bovy PR; Spear KL; Olins GM; Blaine EH
    J Pharmacol Exp Ther; 1989 Apr; 249(1):172-6. PubMed ID: 2565386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.